Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
123456
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Urologic Diseases 2017 NCI 5R01CA172603-05 A novel strategy to identify prostate cancer biomarkers for patient management HUANG, JIAOTI DUKE UNIVERSITY NC $329,925
Urologic Diseases 2017 NIMHD 5R01MD007783-04 A Health IT based Psychoeducational Intervention for African American Prostate Cancer RIVERS, BRIAN MOREHOUSE SCHOOL OF MEDICINE GA $263,848
Urologic Diseases 2017 NIDDK 5R01DK104941-03 Wnt responsive stem cells in the prostate SUN, ZIJIE BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $382,500
Urologic Diseases 2017 NICHD 5U01HD077384-03 Optimizing Management of the Second Stage of Labor: Multicenter Randomized Trial CAHILL, ALISON WASHINGTON UNIVERSITY MO $1,710,765
Urologic Diseases 2017 NCI 5R01CA166894-05 A New Mechanism for Castration Resistant Prostate Cancer SUN, ZIJIE BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $1
Urologic Diseases 2017 NIDDK 4R25DK096957-05 A Program to Promote Diversity within the American Society of Andrology GERTON, GEORGE AMERICAN SOCIETY OF ANDROLOGY IL $102,722
Urologic Diseases 2017 NCI 5U01CA194393-03 Quantifying and Characterizing the shared genetic contribution to common cancers LINDSTROEM, SARA UNIVERSITY OF WASHINGTON WA $566,464
Urologic Diseases 2017 NCI 5F31CA200163-02 Determining the mechanisms of selective miRNA packaging for extracellular miRNA secretion in prostate cancer HU, TIANYI UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $35,511
Urologic Diseases 2017 NCI 1K22CA207578-01 INVESTIGATING THE ROLE OF THE TRANSCRIPTIONAL COREGULATOR SRC-2 IN CASTRATION RESISTANT PROSTATE CANCER DASGUPTA, SUBHAMOY ROSWELL PARK CANCER INSTITUTE CORP NY $206,685
Urologic Diseases 2017 NIAID 5R01AI041236-23 Zona Pellucida: Immunopathologic Study TUNG, KENNETH UNIVERSITY OF VIRGINIA VA $395,000
Urologic Diseases 2017 NIAID 5R01AI107052-04 Two-component system interactions as uropathogenic Escherichia coli drug targets HADJIFRANGISKOU, MARIA VANDERBILT UNIVERSITY MEDICAL CENTER TN $394,304
Urologic Diseases 2017 NIAID 5R01AI106007-04 Molecular Clonality of Uropathogenic E. Coli SOKURENKO, EVGENI UNIVERSITY OF WASHINGTON WA $738,547
Urologic Diseases 2017 NIAID 5F30AI112252-03 Catalytic mechanism of the usher in pilus biogenesis by uropathogenic E. coli WERNEBURG, GLENN STATE UNIVERSITY NEW YORK STONY BROOK NY $49,044
Urologic Diseases 2017 NIAID 5R01AI060584-11 Parameters governing infection with BK polyomavirus IMPERIALE, MICHAEL UNIVERSITY OF MICHIGAN MI $381,175
Urologic Diseases 2017 NIAID 5R21AI121700-02 Synergistic Photodynamic Therapy for Catherer-Associated Urinary Tract Infections HAMBLIN, MICHAEL MASSACHUSETTS GENERAL HOSPITAL MA $228,995
Urologic Diseases 2017 NCI 5R21CA191913-02 Auger Electron Radiotherapy of Late-Stage, Castration-Resistant Prostate Cancer using a Brominated Dihydrotestosterone Analogue VEACH, DARREN SLOAN-KETTERING INST CAN RESEARCH NY $229,550
Urologic Diseases 2017 NIGMS 5R01GM070855-11 Carbohydrate force fields for structure, dynamics and molecular recognition MACKERELL, ALEXANDER UNIVERSITY OF MARYLAND BALTIMORE MD $324,622
Urologic Diseases 2017 NIDDK 5F30DK104446-03 Sex differences in uropathogenic Escherichia coli urinary tract infection OLSON, PATRICK WASHINGTON UNIVERSITY MO $49,044
Urologic Diseases 2017 NIDDK 5F32DK104544-03 Tryptase - PAR2 axis involved in urinary voiding dysfunction ROMAN, KENNY NORTHWESTERN UNIVERSITY AT CHICAGO IL $60,990
Urologic Diseases 2017 NCI 5R01CA195476-02 Reproducibility of Hyperpolarized Pyruvate Metabolic Imaging in Prostate Cancer KESHARI, KAYVAN SLOAN-KETTERING INST CAN RESEARCH NY $287,816
Urologic Diseases 2017 NCI 2R01CA155232-07 The role of macroH2A variants in cancer and senescence GAMBLE, MATTHEW ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $382,013
Urologic Diseases 2017 NIAID 5R01AI110740-02 Catheter associated urinary tract infection by Pseudomonas aeruginosa LEE, VINCENT UNIV OF MARYLAND, COLLEGE PARK MD $432,835
Urologic Diseases 2017 NIAID 5R21AI121639-02 Small Molecule Inhibition of Pilus Biogenesis by Pathogenic Bacteria THANASSI, DAVID STATE UNIVERSITY NEW YORK STONY BROOK NY $211,391
Urologic Diseases 2017 NIEHS 5R01ES016591-08 Sertoli cell toxicant injury and mechanisms of testicular germ cell apoptosis RICHBURG, JOHN UNIVERSITY OF TEXAS, AUSTIN TX $337,734
Urologic Diseases 2017 NIGMS 5R01GM112776-03 Evolutionary turnover of tissue-specific transcriptomes in Drosophila KOPP, ARTYOM UNIVERSITY OF CALIFORNIA AT DAVIS CA $272,003
Urologic Diseases 2017 NCI 5R01CA192669-03 Dual Targeting of AR and HIF1 to promote radiosensitization of prostate cancer LARNER, JAMES UNIVERSITY OF VIRGINIA VA $412,055
Urologic Diseases 2017 NIAID 5R01AI116791-02 Vaccine to prevent E. coli urinary tract infection MOBLEY, HARRY UNIVERSITY OF MICHIGAN MI $387,933
Urologic Diseases 2017 NCI 5K05CA175147-04 Aggressive Prostate Cancer: Linking Epigenomics and Genetics for Prevention STANFORD, JANET FRED HUTCHINSON CANCER RESEARCH CENTER WA $88,959
Urologic Diseases 2017 NCI 5R01CA193331-02 Reducing the Effects of Active Surveillance Stress, Uncertainty and Rumination thru Engagement in Mindfulness Education (REASSURE ME) VICTORSON, DAVID NORTHWESTERN UNIVERSITY AT CHICAGO IL $513,284
Urologic Diseases 2017 NICHD 5R01HD082065-02 Cisplatin-induced epigenomic modifications in male germ cells WILKINSON, MILES UNIVERSITY OF CALIFORNIA SAN DIEGO CA $321,563
Urologic Diseases 2017 NCI 5R01CA181605-04 Non Invasive Biomarkers for Diagnosing Clinically Significant Prostate Cancer NELSON, PETER FRED HUTCHINSON CANCER RESEARCH CENTER WA $351,588
Urologic Diseases 2017 NIGMS 5R01GM112846-03 Multivalent higher-order complexes regulate ubiquitination in Hedgehog signaling MITTAG, TANJA ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $310,984
Urologic Diseases 2017 NIAID 5R21AI121545-02 Bacteriophage to treat UTI caused by multidrug-resistant P. aeruginosa RAMIG, ROBERT BAYLOR COLLEGE OF MEDICINE TX $217,938
Urologic Diseases 2017 NCI 5R21CA195313-02 Magi2 in aggressive prostate cancer MARKER, PAUL UNIVERSITY OF WISCONSIN-MADISON WI $195,054
Urologic Diseases 2017 NIDDK 5F32DK104516-03 Understanding the role of inflammation, fibrinogen and neutrophils in persistence of E. faecalis during CAUTI FLORES-MIRELES, ANA WASHINGTON UNIVERSITY MO $60,990
Urologic Diseases 2017 NIAID 5R01AI048689-17 PATHOGENIC FIBER FORMATION IN BACTERIA: STRUCTURAL BASIS HULTGREN, SCOTT WASHINGTON UNIVERSITY MO $383,019
Urologic Diseases 2017 NCI 5R01CA190636-02 Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery NELSON, CHRISTIAN SLOAN-KETTERING INST CAN RESEARCH NY $693,571
Urologic Diseases 2017 NIAID 5R01AI116706-02 The role of the urethral microbiome in idiopathic urethritis in men NELSON, DAVID INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $731,160
Urologic Diseases 2017 NCI 5R01CA201430-02 p53 Variants in Cancer Risk and Therapy MURPHY, MAUREEN WISTAR INSTITUTE PA $421,358
Urologic Diseases 2017 NCI 5K07CA166462-05 Impact of Cancer on Adherence in Diabetes LIN, JENNY ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $167,805
Urologic Diseases 2017 NIGMS 5R01GM085267-08 Biosynthesis of Polysaccharides WANG, PENG GEORGIA STATE UNIVERSITY GA $296,000
Urologic Diseases 2017 NCI 5R01CA193739-02 Novel targeted chemo/immunotherapy approach for localized and metastatic CaP BHAT, MOHAMMAD SALEEM UNIVERSITY OF MINNESOTA MN $354,563
Urologic Diseases 2017 NCI 5R01CA101753-13 Anticarcinogenic Effect of ITCs Against Prostate Cancer SINGH, SHIVENDRA UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $346,500
Urologic Diseases 2017 NCI 5R01CA181242-03 Identification of DNA methylation markers for risk of metastasis in localized pro CHAO, CHUN KAISER FOUNDATION RESEARCH INSTITUTE CA $566,816
Urologic Diseases 2017 NCI 5R01CA200844-02 Lipid-dendrimer micellar nanocarriers for siRNA/drug co-delivery in MDR cancer TORCHILIN, VLADIMIR NORTHEASTERN UNIVERSITY MA $341,201
Urologic Diseases 2017 NCI 5R01CA200787-02 Development of small molecules for ERG ablation in prostate cancer KITTLER, RALF UT SOUTHWESTERN MEDICAL CENTER TX $370,575
Urologic Diseases 2017 NCI 5R01CA200611-02 Developing therapeutics against resistance to the androgen-deprivation therapy YU, QIN ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $387,731
Urologic Diseases 2017 NCI 5R01CA193829-02 Prostate-Specific Androgen Transporters are the Missing Target for Complete ADT SMITH, GARY ROSWELL PARK CANCER INSTITUTE CORP NY $392,306
Urologic Diseases 2017 NIBIB 5R01EB016707-04 Protein Biomarker Arrays for Personalized Treatment of Prostate Cancer RUSLING, JAMES UNIVERSITY OF CONNECTICUT STORRS CT $348,141
Urologic Diseases 2017 NCI 5R01CA172220-05 Estrogen Receptors in Human Prostate Stem-Progenitor Cells PRINS, GAIL UNIVERSITY OF ILLINOIS AT CHICAGO IL $330,527
Urologic Diseases 2017 NCI 5R01CA190289-03 Compensatory steroidogenesis mechanisms in castration-resistant prostate cancer SHARIFI, NIMA CLEVELAND CLINIC LERNER COM-CWRU OH $362,569
Urologic Diseases 2017 NCI 5R01CA182587-04 Defining the temporal sequence of PI3K pathway mutations in bladder cancer SOLIT, DAVID SLOAN-KETTERING INST CAN RESEARCH NY $368,728
Urologic Diseases 2017 NCI 5R01CA183929-03 Molecular mechanisms of prostate cancer metastasis ABATE-SHEN, CORY COLUMBIA UNIVERSITY HEALTH SCIENCES NY $366,000
Urologic Diseases 2017 NCI 5R44CA192701-03 NanoCytology to mitigate overdiagnosis of prostate cancer SUBRAMANIAN, HARIHARAN NANOCYTOMICS, LLC IL $782,124
Urologic Diseases 2017 NCI 5R01CA176401-04 RB Function in Prostate Cancer Progression KNUDSEN, KAREN THOMAS JEFFERSON UNIVERSITY PA $431,269
Urologic Diseases 2017 NCI 5R00CA175291-04 CD117 Signaling as a Mechanism of Prostate Cancer Metastasis KERR, BETHANY WAKE FOREST UNIVERSITY HEALTH SCIENCES NC $249,000
Urologic Diseases 2017 NIEHS 5K99ES025231-02 Retinoic Acid Signaling Disruption by Phthalates in Human and Rodent Fetal Testis SPADE, DANIEL BROWN UNIVERSITY RI $100,210
Urologic Diseases 2017 NCI 5R01CA070297-19 Androgen Signaling in prostate cancer progression and CRPC development SUN, ZIJIE BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $1
Urologic Diseases 2017 NCI 5R01CA196232-02 Effectors of protein kinase C-mediated tumor progression KAZANIETZ, MARCELO UNIVERSITY OF PENNSYLVANIA PA $389,662
Urologic Diseases 2017 NCI 5P30CA014236-43 5331 Solid Tumor Therapeutics Research Program KASTAN, MICHAEL DUKE UNIVERSITY NC $41,908
Urologic Diseases 2017 NIGMS 5R01GM059152-18 DMRT1 in Mammalian Sexual Development ZARKOWER, DAVID UNIVERSITY OF MINNESOTA MN $650,907
Urologic Diseases 2017 NCI 5R01CA136924-08 Prostate Cancer Risk Enhancers FARNHAM, PEGGY UNIVERSITY OF SOUTHERN CALIFORNIA CA $556,779
Urologic Diseases 2017 NCI 5R01CA164574-05 Gender Disparity in Bladder Cancer and Chemopreventive Intervention ZHANG, YUESHENG ROSWELL PARK CANCER INSTITUTE CORP NY $325,312
Urologic Diseases 2017 NIGMS 5R01GM110019-03 Molecular mechanism of mTORC1-dependent translation and ribosome biogenesis INOKI, KEN UNIVERSITY OF MICHIGAN MI $289,468
Urologic Diseases 2017 NCI 5R01CA173986-04 Exosomes: A novel mechanism for bladder cancer tumorigenesis and progression LEE, YI-FEN UNIVERSITY OF ROCHESTER NY $376,236
Urologic Diseases 2017 NCI 5R21CA202552-02 Comparative Effectiveness of Genomics Assay for Active Surveillance Failure Prediction in African American Men: the impact of genetic ancestry and socioeconomic status. MURPHY, ADAM NORTHWESTERN UNIVERSITY AT CHICAGO IL $174,014
Urologic Diseases 2017 NIAID 5R01AI059722-12 Molecular mechanisms of uropathogenesis MOBLEY, HARRY UNIVERSITY OF MICHIGAN MI $399,610
Urologic Diseases 2017 NIDDK 5F31DK104528-03 KCNQ Channels of the Urinary Bladder: A Functional Role and Therapeutic Potential PROVENCE, AARON UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA SC $32,152
Urologic Diseases 2017 NCI 5R01CA174206-05 Bioinformatics Tools for Genomic Analysis of Tumor and Stromal Pathways in Cancer PARMIGIANI, GIOVANNI DANA-FARBER CANCER INST MA $324,548
Urologic Diseases 2017 NCI 5K22CA174841-03 PSMA Targeted Docetaxel Loaded Magnetic Nanoparticles for Prostate Cancer Therapy YALLAPU, MURALI UNIVERSITY OF TENNESSEE HEALTH SCI CTR TN $160,992
Urologic Diseases 2017 NCI 5R01CA181189-04 Functional Role of Bone Marrow Adipocytes in Metastatic Prostate Cancer PODGORSKI, IZABELA WAYNE STATE UNIVERSITY MI $315,400
Urologic Diseases 2017 NIDDK 5R01DK107436-02 Molecular Mechanisms of Initiation of Benign Prostatic Hyperplasia XIN, LI BAYLOR COLLEGE OF MEDICINE TX $356,625
Urologic Diseases 2017 NIDDK 5R01DK080099-07 Genetics of Human Renal Hypodysplasia GHARAVI, ALI COLUMBIA UNIVERSITY HEALTH SCIENCES NY $500,556
Urologic Diseases 2017 NCI 5R01CA193437-02 Regulation of Urinary Bladder Carcinogenesis and Progression by SPARC SAID, NEVEEN WAKE FOREST UNIVERSITY HEALTH SCIENCES NC $354,563
Urologic Diseases 2017 NIAID 5F31AI106357-05 UTI Immune Modulation by LPS Structure AGUINIGA, LIZATH NORTHWESTERN UNIVERSITY AT CHICAGO IL $36,720
Urologic Diseases 2017 NCI 5P30CA008748-51 7555 Antitumor DE STANCHINA, ELISA SLOAN-KETTERING INST CAN RESEARCH NY $253,618
Urologic Diseases 2017 NCI 5P30CA008748-51 7564 Organic Sythesis OUERFELLI, OUATHEK SLOAN-KETTERING INST CAN RESEARCH NY $342,882
Urologic Diseases 2017 NCI 5P30CA008748-51 7575 Web Survey Core VICKERS, ANDREW SLOAN-KETTERING INST CAN RESEARCH NY $166,422
Urologic Diseases 2017 NCI 5P30CA008748-51 7582 Bioinfomatics SOCCI, NICHOLAS SLOAN-KETTERING INST CAN RESEARCH NY $828,317
Urologic Diseases 2017 NCI 5R00CA160640-05 Tracing the origins of chromosomal translocations in prostate cancer MANI, RAM UT SOUTHWESTERN MEDICAL CENTER TX $249,000
Urologic Diseases 2017 NCI 5R01CA190554-03 Osteocytes in prostate cancer bone metastasis KELLER, EVAN UNIVERSITY OF MICHIGAN MI $354,563
Urologic Diseases 2017 NIDDK 5R01DK078158-08 Neural Crest Contributions to the Lower Urinary Tract SOUTHARD-SMITH, E MICHELLE VANDERBILT UNIVERSITY MEDICAL CENTER TN $343,650
Urologic Diseases 2017 NIAID 5R44AI100332-05 Optimization of novel pyranopyridine efflux pump inhibitors OPPERMAN, TIMOTHY MICROBIOTIX, INC MA $742,587
Urologic Diseases 2017 NIDDK 5R01DK107807-02 Opiorphin as a master regulator of pathways leading to priapism DAVIES, KELVIN ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $488,475
Urologic Diseases 2017 NCI 5R01CA184208-03 Genetic & Metabolic Dissection of the CaMKKbeta Signaling Axis in Prostate Cancer FRIGO, DANIEL UNIVERSITY OF HOUSTON TX $349,759
Urologic Diseases 2017 NIBIB 5R01EB020353-02 Theranostic gold nanoparticles for imaged-guided radical prostatectomy and PDT ablation BASILION, JAMES CASE WESTERN RESERVE UNIVERSITY OH $664,240
Urologic Diseases 2017 NCI 5R01CA200718-02 A Multilevel Intervention to Increase the Participation of African Americans in Prostate Cancer Clinical Trials EGGLY, SUSAN WAYNE STATE UNIVERSITY MI $599,514
Urologic Diseases 2017 NIAID 5R01AI117058-03 Rapid detection of pathogens and antimicrobial susceptibility directly in patient samples GITE, SADANAND FIRST LIGHT BIOSCIENCES, INC. MA $879,278
Urologic Diseases 2017 NIAID 5K23AI121516-02 Clinical Sequelae and Urogenital Viral Dynamics in Survivors of Ebola Virus Disease FISCHER, WILLIAM UNIV OF NORTH CAROLINA CHAPEL HILL NC $199,568
Urologic Diseases 2017 NCI 5R00CA175290-05 An integrated approach to dissect the functional network of large non-coding RNA CHEN, YIWEN UNIVERSITY OF TX MD ANDERSON CAN CTR TX $221,939
Urologic Diseases 2017 NCI 5R01CA202690-02 Circadian Disruption and Risk of Prostate Cancer in a Multiethnic Cohort MUCCI, LORELEI HARVARD SCHOOL OF PUBLIC HEALTH MA $393,034
Urologic Diseases 2017 NIGMS 1SC2GM121185-01 Development of Stabilized Zampanolide Mimics as Chemotherapeutics for Prostate Cancer CHEN, QIAOHONG CALIFORNIA STATE UNIVERSITY FRESNO CA $140,000
Urologic Diseases 2017 NCI 2P30CA006516-52 5398 Program 3: Prostate Cancer BALK, STEVEN BETH ISRAEL DEACONESS MEDICAL CENTER MA $40,304
Urologic Diseases 2017 NIDDK 5R01DK054740-17 Pax2 Interacting Proteins in Development and Disease DRESSLER, GREGORY UNIVERSITY OF MICHIGAN MI $520,534
Urologic Diseases 2017 NIDDK 5R01DK054468-14 Mitochondrial Metabolism in Primary Hyperoxaluria HOLMES, ROSS UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $320,166
Urologic Diseases 2017 NCI 5R01CA202814-02 Diagnosis and longitudinal monitoring of metastatic prostate cancer through molecular MR imaging STEINMETZ, NICOLE CASE WESTERN RESERVE UNIVERSITY OH $394,519
Urologic Diseases 2017 NCI 2P30CA012197-42 6112 Tumor Progression and Recurrence (01) PASCHE, BORIS WAKE FOREST UNIVERSITY HEALTH SCIENCES NC $49,492
Urologic Diseases 2017 NCI 2P30CA076292-19 6173 Health Outcomes & Behavior BRANDON, THOMAS H. LEE MOFFITT CANCER CTR & RES INST FL $34,859
Urologic Diseases 2017 NCI 5R01CA183857-04 Exploiting drivers of androgen receptor signaling negative prostate cancer for pr TOMLINS, SCOTT UNIVERSITY OF MICHIGAN MI $321,625
Urologic Diseases 2017 NIDDK 1R01DK111382-01 Parasympathetic and sympathetic mechanisms underlying bladder nociception DEGROAT, WILLIAM UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $348,188
Urologic Diseases 2017 NCI 5R21CA202214-02 Detection of High Grade Prostate Cancer with Subharmonic Ultrasound Imaging HALPERN, ETHAN THOMAS JEFFERSON UNIVERSITY PA $206,883
Urologic Diseases 2017 NIAID 5R01AI123083-02 Structure-Function Analysis of Chlamydia Secretion Chaperones VALDIVIA, RAPHAEL DUKE UNIVERSITY NC $517,940
Urologic Diseases 2017 NIDDK 5R01DK105068-03 Prune Belly Syndrome BAKER, LINDA UT SOUTHWESTERN MEDICAL CENTER TX $368,866
Urologic Diseases 2017 NIAID 5R42AI116114-03 Clonotyping Technology for Prediction of Antibiotic Resistance SOKURENKO, EVGENI IDGENOMICS, INC. WA $987,986
Urologic Diseases 2017 NCI 5R01CA168601-05 Novel roles of microRNA in androgen receptor signaling GAO, ALLEN UNIVERSITY OF CALIFORNIA AT DAVIS CA $308,025
Urologic Diseases 2017 NCI 5R35CA197465-02 Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance RONAI, ZE'EV SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE CA $1,137,453
Urologic Diseases 2017 NINDS 1R01NS099076-01 Spinal dopaminergic mechanisms regulating the micturition reflex after spinal cord injury HOU, SHAOPING DREXEL UNIVERSITY PA $341,252
Urologic Diseases 2017 NIAID 5R21AI105712-02 Chlamydia Vaccine---Global search for chlamydial T cell antigens in HLA-DR4 transgenic mice ZHONG, GUANGMING UNIVERSITY OF TEXAS HLTH SCIENCE CENTER TX $191,205
Urologic Diseases 2017 NIA 5R01AG049321-02 Nox Enzymes in Aging Bladder Dysfunction RUGGIERI, MICHAEL TEMPLE UNIV OF THE COMMONWEALTH PA $269,077
Urologic Diseases 2017 NCI 5R35CA197684-02 IKK/NF-kappaB Signaling in Cancer: Therapy, Resistance, and Tumor Initiating Cells BALDWIN, ALBERT UNIV OF NORTH CAROLINA CHAPEL HILL NC $848,325
Urologic Diseases 2017 NIBIB 5R03EB022141-02 Towards an Effective Prostate Cancer-Targeting Biomaterial CONDA SHERIDAN, MARTIN UNIVERSITY OF NEBRASKA MEDICAL CENTER NE $75,250
Urologic Diseases 2017 NCI 1R01CA212094-01 Inhibition of castration resistant prostate cancer by targeting of the IKKbeta/AR signaling DAN, HANCAI UNIVERSITY OF MARYLAND BALTIMORE MD $366,943
Urologic Diseases 2017 NCI 1R01CA211646-01 Assays to Identify Prostate Cancer Therapeutics Targeting Antizyme Inhibitor ZETTER, BRUCE BOSTON CHILDREN'S HOSPITAL MA $415,154
Urologic Diseases 2017 NCI 5R01CA157429-05 Overcoming drug resistance of castration-resistant prostate cancer LIU, XIAOQI PURDUE UNIVERSITY IN $257,688
Urologic Diseases 2017 NCI 5R01CA182435-03 Neuropilin-2 Axis in Docetaxel Resistance and Prostate Cancer Bone Metastasis DATTA, KAUSTUBH UNIVERSITY OF NEBRASKA MEDICAL CENTER NE $344,269
Urologic Diseases 2017 NCI 5R01CA192894-02 Enhancing anti-neoplastic activity of metformin in prostate cancer LIU, XIAOQI PURDUE UNIVERSITY IN $357,624
Urologic Diseases 2017 NIGMS 5R01GM111084-03 Structural and Mechanistic Studies of the Mitochondrial Protein Folding Machinery TSAI, FRANCIS BAYLOR COLLEGE OF MEDICINE TX $340,642
Urologic Diseases 2017 NCI 5R01CA183965-04 Role of TOP2B in generating complex genomic rearrangements in human cancer YEGNASUBRAMANIAN, SRINIVASAN JOHNS HOPKINS UNIVERSITY MD $336,150
Urologic Diseases 2017 NCI 5R01CA200551-02 A Phase II Evaluation of SABR in Oligometastatic Castration-Refractory Prostate Cancer and Immunogenicity of SABR PARK, SEAN MAYO CLINIC ROCHESTER MN $247,249
Urologic Diseases 2017 NCI 5R01CA160902-06 Advancement and Validation of Prostate Diffusion and Spectroscopic MRI MAIER, STEPHAN BRIGHAM AND WOMEN'S HOSPITAL MA $220,860
Urologic Diseases 2017 NCI 5R01CA143971-07 Understanding the AGL metastasis suppressor for therapeutic gain THEODORESCU, DAN UNIVERSITY OF COLORADO DENVER CO $435,425
Urologic Diseases 2017 NIDDK 1K23DK111987-01 Engaging families to improve the care of patients with hypospadias. CHAN, KATHERINE INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $180,068
Urologic Diseases 2017 NCI 1K99CA212292-01 Elucidating a Novel Mechanism for SPOP in Suppressing Prostate Tumorigenesis ZHANG, JINFANG BETH ISRAEL DEACONESS MEDICAL CENTER MA $168,804
Urologic Diseases 2017 NCI 5R01CA116161-08 Towards a non-invasive molecular test for bladder cancer GOODISON, STEVE MAYO CLINIC JACKSONVILLE FL $373,690
Urologic Diseases 2017 FIC 5D43TW009578-05 Male Circumcision and Use of Foreskin Tissues for HIV Prevention in Uganda GRAY, RONALD JOHNS HOPKINS UNIVERSITY MD $265,216
Urologic Diseases 2017 NCI 1R21CA212516-01 Enhancing Survivorship Care Planning for Patients with Localized Prostate Cancer Using A Couple-focused Web-based Tailored Symptom Self-management Program SONG, LIXIN UNIV OF NORTH CAROLINA CHAPEL HILL NC $198,360
Urologic Diseases 2017 NIAID 1R21AI128313-01 Emergence of ST-11 Neisseria meningitidis as a sexually transmitted pathogen TZENG, YIH-LING EMORY UNIVERSITY GA $234,000
Urologic Diseases 2017 NCI 1R21CA213020-01 Hyperpolarized 13C imaging of mitochondrial metabolism for improved characterization of prostate cancer MAYER, DIRK UNIVERSITY OF MARYLAND BALTIMORE MD $167,702
Urologic Diseases 2017 NCI 1R21CA212628-01 Leukocyte telomere length in bladder cancer survivors: Diet and exercise trial BOVBJERG, DANA UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $168,291
Urologic Diseases 2017 NCI 5R01CA176844-05 The Hippo Pathway in Prostate Gland Homeostasis and Prostate Cancer VASIOUKHIN, VALERI FRED HUTCHINSON CANCER RESEARCH CENTER WA $362,148
Urologic Diseases 2017 NCI 5R01CA178431-04 Function of the Stem Cell Transcription Factor Sox2 in Prostate Cancer VANDER GRIEND, DONALD UNIVERSITY OF CHICAGO IL $323,229
Urologic Diseases 2017 NCI 1R21CA213157-01 Radiolabeled FASN Inhibitors for PET Imaging BABICH, JOHN WEILL MEDICAL COLL OF CORNELL UNIV NY $229,013
Urologic Diseases 2017 NCI 5R01CA169524-05 Role of RNF6 in survival signaling QIU, YUN UNIVERSITY OF MARYLAND BALTIMORE MD $318,513
Urologic Diseases 2017 NIDDK 5F31DK107057-02 Delineating the role of inflammation and the microbiota in uropathogenic E. coli intestinal colonization SPAULDING, CAITLIN WASHINGTON UNIVERSITY MO $30,398
Urologic Diseases 2017 NCI 5R01CA186780-22 Roles of EAF2 in androgen action in the prostate WANG, ZHOU UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $371,525
Urologic Diseases 2017 NCI 5R01CA112226-08 Transcription repression in prostate cancer LOGAN, SUSAN NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $402,563
Urologic Diseases 2017 NIAID 5R01AI110666-04 Male urethritis: Novel etiologies and natural history MANHART, LISA UNIVERSITY OF WASHINGTON WA $763,062
Urologic Diseases 2017 NCI 5R01CA193910-03 Defining the epigenetic landscape in human prostate cancer FREEDMAN, MATTHEW DANA-FARBER CANCER INST MA $633,613
Urologic Diseases 2017 NCI 1R03CA212556-01 Loss of novel end joining factor with dysfunction of BRCA1 contributes to treatment resistance TOMIDA, JUNYA UNIVERSITY OF TX MD ANDERSON CAN CTR TX $80,000
Urologic Diseases 2017 NCI 1R03CA212567-01 the role of EZH2 in neuroendocrine prostate cancer YU, XIUPING LOUISIANA STATE UNIV HSC SHREVEPORT LA $72,500
Urologic Diseases 2017 NIAID 5R01AI116471-02 TRANSMISSION DYNAMICS OF MULTI-DRUG RESISTANT UROPATHOGENIC E. coli IN BANGLADESH ISLAM, MOHAMMAD INTERNATIONAL CTR/DIARRHOEAL DIS RES BANGLA $126,852
Urologic Diseases 2017 NIAID 5R21AI123747-02 Mechanisms and implications of fosfomycin resistance in Escherichia coli DOI, YOHEI UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $191,000
Urologic Diseases 2017 NCI 1R15CA202984-01A1 Oncolytic reovirus modulation of the cancer cell hypoxic response MILLER, CATHY IOWA STATE UNIVERSITY IA $441,245
Urologic Diseases 2017 NCI 5F30CA196108-03 Functional Investigation of the Mitochondrial Pyruvate Carrier in Prostate Cancer BADER, DAVID BAYLOR COLLEGE OF MEDICINE TX $38,455
Urologic Diseases 2017 NCI 5R01CA127923-10 IKK and the Control of Prostate Cancer Metastasis KARIN, MICHAEL UNIVERSITY OF CALIFORNIA SAN DIEGO CA $257,099
Urologic Diseases 2017 NCI 5R01CA174798-05 Endothelial-to-osteoblast transition in prostate cancer bone metastasis LIN, SUE-HWA UNIVERSITY OF TX MD ANDERSON CAN CTR TX $88,988
Urologic Diseases 2017 NIDDK 5R01DK088767-08 New genes and pathomechanisms of congenital abnormalities of the kidney (CAKUT) HILDEBRANDT, FRIEDHELM BOSTON CHILDREN'S HOSPITAL MA $398,250
Urologic Diseases 2017 NCI 5R01CA172576-04 Translating Novel Antitumor Targets of Vitamin E into New Chemopreventive Agents CHEN, CHING-SHIH OHIO STATE UNIVERSITY OH $319,550
Urologic Diseases 2017 NIDDK 1R01DK108840-01A1 SMALL MOLECULE BACTERIAL LECTIN ANTAGONISTS FOR UTI TREATMENT AND PREVENTION JANETKA, JAMES WASHINGTON UNIVERSITY MO $485,650
Urologic Diseases 2017 NCI 5R01CA193442-03 Investigating the cell of origin for bladder cancer ABATE-SHEN, CORY COLUMBIA UNIVERSITY HEALTH SCIENCES NY $474,774
Urologic Diseases 2017 NIA 2R37AG032982-06 Trial to Reduce Antimicrobial Use in Nursing home residents with Alzheimer's disease and other Dementias (TRAIN-AD) MITCHELL, SUSAN HEBREW REHABILITATION CENTER FOR AGED MA $834,102
Urologic Diseases 2017 NCI 2R01CA105304-11A1 Delineating the mechanisms of androgen receptor activation function-1 antagonists for development of novel prostate cancer therapeutics SADAR, MARIANNE BRITISH COLUMBIA CANCER AGENCY CANADA $260,847
Urologic Diseases 2017 NCI 5R01CA197516-02 3D Prostate Histochemometry to Predict Disease Recurrence BHARGAVA, ROHIT UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN IL $400,626
Urologic Diseases 2017 NINDS 5R01NS069765-07 Recovery of Bladder Reflexes and Nerve Regeneration after Spinal Cord Injury LEE, YU-SHANG CLEVELAND CLINIC LERNER COM-CWRU OH $346,719
Urologic Diseases 2017 NCI 5K23CA197526-02 Overcoming drug resistance in metastatic castration resistant prostate cancer with a novel combination of TGF-beta inhibition and enzalutamide PALLER, CHANNING JOHNS HOPKINS UNIVERSITY MD $177,120
Urologic Diseases 2017 NIBIB 5R21EB021482-02 Instructive Biomaterial Designs for Urethroplasty MAUNEY, JOSHUA BOSTON CHILDREN'S HOSPITAL MA $265,500
Urologic Diseases 2017 NCI 1R01CA201035-01A1 Kallikrein-Targeted Alpha-Particle Therapy of Late-Stage Prostate Cancer THOREK, DANIEL JOHNS HOPKINS UNIVERSITY MD $373,340
Urologic Diseases 2017 NCI 1R01CA203930-01A1 Biobehavioral Effects of Qigong for Prostate Cancer Survivors with Fatigue KINNEY, ANITA UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR NM $623,021
Urologic Diseases 2017 NCI 5R01CA204430-02 Mitochondria in Prostate Cancer Diversity SINGH, KESHAV UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $336,263
Urologic Diseases 2017 NCI 1R01CA204254-01A1 Academic-Industrial Partnership for Translation of PET/TRUS Guided Intervention FEI, BAOWEI EMORY UNIVERSITY GA $376,753
Urologic Diseases 2017 NICHD 2R01HD052937-11 Cellular plasticity and testis regeneration MATUNIS, ERIKA JOHNS HOPKINS UNIVERSITY MD $225,630
Urologic Diseases 2017 NCI 5U10CA180795-04 Building upon a tradition of excellence. The NCTN at Indiana University MILLER, KATHY INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $519,002
Urologic Diseases 2017 NCI 1R01CA202261-01A1 Improving HPV Vaccination Delivery in Pediatric Primary Care: The STOP-HPV Trial SZILAGYI, PETER UNIVERSITY OF CALIFORNIA LOS ANGELES CA $676,337
Urologic Diseases 2017 NCI 5R01CA175112-04 Development of anti-angiogenesis therapy targeting integrin LIU, ZHI-REN GEORGIA STATE UNIVERSITY GA $393,091
Urologic Diseases 2017 NCI 5R21CA194798-02 Exploring high-does testosterone as a potential treatment for abiraterone-resistant prostate cancer COREY, EVA UNIVERSITY OF WASHINGTON WA $201,623
Urologic Diseases 2017 NCI 5R21CA197887-02 Autophagy regulation of prostate tumor development THORBURN, ANDREW UNIVERSITY OF COLORADO DENVER CO $169,106
Urologic Diseases 2017 NCI 1R01CA206592-01A1 Structural Mechanisms of Hedgehog Autoprocessing in Physiology and Disease WANG, CHUNYU RENSSELAER POLYTECHNIC INSTITUTE NY $400,728
Urologic Diseases 2017 NIDDK 1R01DK109314-01A1 The microtubule cytoskeleton as a novel target for cavernous nerve regeneration after prostatectomy DAVIES, KELVIN ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $578,367
Urologic Diseases 2017 NIDDK 2R01DK087967-06 Oxalobacter formigenes colonization and oxalate excretion in calcium oxalate kidney stone disease KNIGHT, JOHN UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $442,131
Urologic Diseases 2017 NIDDK 5R44DK107094-03 Non-invasive Promotion of Clearance of Kidney Stones and Fragments LEVY, OREN SONOMOTION, INC. CA $763,045
Urologic Diseases 2017 NCI 5R01CA206222-02 Targeting key orphan nuclear receptor in lethal prostate cancer CHEN, HONGWU UNIVERSITY OF CALIFORNIA AT DAVIS CA $359,138
Urologic Diseases 2017 NIEHS 5R01ES014032-08 Cancer in adults following in utero and early life exposure to arsenic STEINMAUS, CRAIG UNIVERSITY OF CALIFORNIA BERKELEY CA $443,807
Urologic Diseases 2017 NIDDK 1R01DK108434-01A1 Barrier integrity, microbiome and HIV target cell interactions in the human male genital tract pre and post circumcision HOPE, THOMAS NORTHWESTERN UNIVERSITY AT CHICAGO IL $638,625
Urologic Diseases 2017 NIAID 5R01AI117059-03 A fully integrated CentriFluidic system for direct bloodstream infection PID/AST GAU, VINCENT GENEFLUIDICS, INC. CA $704,237
Urologic Diseases 2017 NICHD 5R01HD081792-03 Defective melanocortin signaling underlying T2D-associated erectile dysfunction HILL, JENNIFER UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS OH $294,412
Urologic Diseases 2017 NIAID 5R01AI099099-05 BIOGENESIS AND INHIBITION OF BIOFILM-ASSOCIATED BACTERIAL AMYLOID HULTGREN, SCOTT WASHINGTON UNIVERSITY MO $380,000
Urologic Diseases 2017 NCI 5K08CA175154-06 Defining the role of eIF4F in metastatic castration resistant prostate cancer HSIEH, ANDREW FRED HUTCHINSON CANCER RESEARCH CENTER WA $169,560
Urologic Diseases 2017 NIDDK 5R01DK106286-03 The interface between critical acid-base mediators and the renal bacterial defense SCHWADERER, ANDREW RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $392,793
Urologic Diseases 2017 NCI 2U01CA167552-06 Cancer Epidemiology Cohort in Male Health Professionals WILLETT, WALTER HARVARD SCHOOL OF PUBLIC HEALTH MA $1,884,447
Urologic Diseases 2017 NIAID 1K08AI123524-01A1 Investigating a Novel Co-regulation of Multi-Drug Efflux Pumps and Polysaccharide Capsule in E. coli ARSHAD, MEHREEN DUKE UNIVERSITY NC $188,478
Urologic Diseases 2017 NCI 5R01CA125535-10 Mechanism of beta-Catenin and APC-Regulated Transcription at Wnt Target Genes JONES, KATHERINE SALK INSTITUTE FOR BIOLOGICAL STUDIES CA $452,288
Urologic Diseases 2017 NCI 5R01CA193837-03 Defining the Role of ERG in Modulating the AR Cistrome and Antiandrogen Sensitivity SAWYERS, CHARLES SLOAN-KETTERING INST CAN RESEARCH NY $468,128
Urologic Diseases 2017 NCI 5R01CA181802-04 Effect of Aerobic Exercise on Genomic Signatures of Prostate Cancer Prognosis CHAN, JUNE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $627,846
Urologic Diseases 2017 NCI 5R00CA184397-04 Proteolytically Cleaved Receptors as Oncogenes and Therapeutic Targets STOYANOVA, TANYA STANFORD UNIVERSITY CA $242,996
Urologic Diseases 2017 NCI 5F30CA203472-02 Clinical bacterial isolate engineered as an immunotherapy for prostate cancer ANKER, JONATHAN NORTHWESTERN UNIVERSITY AT CHICAGO IL $49,044
Urologic Diseases 2017 NCI 5R01CA191002-02 The role of PLK1 in prostate cancer FU, ZHENG VIRGINIA COMMONWEALTH UNIVERSITY VA $348,844
Urologic Diseases 2017 NCI 5R21CA199171-02 Genetic Signatures Underlying Prostate Cancer Metastasis in AfricanAmericans FARUQUE, MEZBAH HOWARD UNIVERSITY DC $131,370
Urologic Diseases 2017 NCI 5R01CA123484-10 Role of Oncogenic Kinase Pim-1 in Prostate Cancer ABDULKADIR, SARKI NORTHWESTERN UNIVERSITY AT CHICAGO IL $284,744
Urologic Diseases 2017 NCI 5R01CA168899-05 Cooperative steroidogenic inhibition for treatment of advanced prostate cancer SHARIFI, NIMA CLEVELAND CLINIC LERNER COM-CWRU OH $326,897
Urologic Diseases 2017 NIDDK 5R03DK109242-02 Novel Mouse Models to Assess the in vivo Significance of Ribonuclease 7 in Urinary Tract Defense SPENCER, JOHN RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $80,248
Urologic Diseases 2017 NICHD 1R21HD087794-01A1 Cortical Signatures of Bladder Activity in Children ZDERIC, STEPHEN CHILDREN'S HOSP OF PHILADELPHIA PA $189,031
Urologic Diseases 2017 NIAID 1R21AI117424-01A1 The role of peptide signaling in Enterococcus faecalis biofilm development HANCOCK, LYNN UNIVERSITY OF KANSAS LAWRENCE KS $222,492
Urologic Diseases 2017 NCI 5R01CA193481-03 Sequence-specific Capture for Discovering Protein-IncRNA Interactions in Prostate Cancer SMITH, LLOYD UNIVERSITY OF WISCONSIN-MADISON WI $344,168
Urologic Diseases 2017 NIDDK 5R01DK051413-16 Quantitative Studies of Urinary Bladder Sensation NESS, TIMOTHY UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $330,750
Urologic Diseases 2017 NIDDK 5R01DK083289-09 Branching Morphogenesis of Urinary Epithelia: from Genes to Cellular Behaviors COSTANTINI, FRANKLIN COLUMBIA UNIVERSITY HEALTH SCIENCES NY $509,171
Urologic Diseases 2017 NIGMS 5R01GM086596-07 Activation of androgen biosynthesis and drug metabolism by cytochrome b5 AUCHUS, RICHARD UNIVERSITY OF MICHIGAN MI $338,571
Urologic Diseases 2017 OD 5K01OD019912-03 The role of zinc transporters and dietary zinc in calcium oxalate urolithiasis FURROW, EVA UNIVERSITY OF MINNESOTA MN $129,816
Urologic Diseases 2017 NCI 5R01CA174777-05 AR Gene Rearrangements and AR Signaling in Prostate Cancer DEHM, SCOTT UNIVERSITY OF MINNESOTA MN $310,149
Urologic Diseases 2017 NCI 5R01CA171189-05 Bidirectional role of KLF5 in prostatic epithelial homeostasis and tumorigenesis DONG, JIN-TANG EMORY UNIVERSITY GA $323,700
Urologic Diseases 2017 NCI 5R44CA203199-02 Novel Androgen Receptor Degraders to Treat Castration-Resistant Prostate Cancer TAYLOR, IAN ARVINAS, INC. CT $402,226
Urologic Diseases 2017 NIDDK 5R01DK104718-02 The Female Urinary Microbiome and Urinary Incontinence WOLFE, ALAN LOYOLA UNIVERSITY CHICAGO IL $643,645
Urologic Diseases 2017 NIAID 5R01AI113927-03 Rapid molecular diagnostic for chlamydia and gonorrhea at the point-of-care KLAPPERICH, CATHERINE BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) MA $409,039
Urologic Diseases 2017 NIAID 5R01AI114710-03 Lipooligosaccharide mimitope vaccines against Neisseria gonorrhoeae RICE, PETER UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $449,255
Urologic Diseases 2017 NCI 5K99CA194289-02 MDSC-tumor crosstalk in prostate cancer progression and castration resistance WANG, GUOCAN UNIVERSITY OF TX MD ANDERSON CAN CTR TX $104,445
Urologic Diseases 2017 NCI 5F30CA203517-02 Role of Neutrophil Elastase in Castration-Sensitive and Resistant Prostate Cancer LERMAN, IRINA UNIVERSITY OF ROCHESTER NY $49,044
Urologic Diseases 2017 NCI 5R01CA125612-09 Towards Understanding Prostate Cancer Heterogeneity RUBIN, MARK WEILL MEDICAL COLL OF CORNELL UNIV NY $372,410
Urologic Diseases 2017 NCI 5R01CA157372-06 VPAC1 Recpetor-Targeted PET Imaging of Prostate Cancer THAKUR, MATHEW THOMAS JEFFERSON UNIVERSITY PA $380,300
Urologic Diseases 2017 NCI 5R01CA176671-05 Annotating Oncogene Status in Prostate Cancer with Zr-89-transferrin PET LEWIS, JASON SLOAN-KETTERING INST CAN RESEARCH NY $563,930
Urologic Diseases 2017 NCI 5R21CA196570-02 Reprogramming of Prostate Stromal Cells by Prostate Inflammation XIN, LI BAYLOR COLLEGE OF MEDICINE TX $185,247
Urologic Diseases 2017 NCI 5R01CA115746-10 Characterizing Prostate Cancer By ex vivo MRS Signatures CHENG, LEO MASSACHUSETTS GENERAL HOSPITAL MA $556,388
Urologic Diseases 2017 NCI 5R01CA187918-03 Targeting the p110beta isoform of PI3 kinase in prostate cancer ROBERTS, THOMAS DANA-FARBER CANCER INST MA $554,053
Urologic Diseases 2017 NCI 5R00CA181342-04 Elucidating a Novel Akt Activation Mechanism for Targeted Prostate Cancer Therapy LIU, PENGDA UNIV OF NORTH CAROLINA CHAPEL HILL NC $217,518
Urologic Diseases 2017 NCI 5R01CA197944-02 Development of cancer therapeutic TBK1/IKKi dual inhibitors LUO, JUN-LI SCRIPPS FLORIDA FL $439,200
Urologic Diseases 2017 NCI 5P30CA014599-42 5653 ADVANCED IMAGING LE BEAU, MICHELLE UNIVERSITY OF CHICAGO IL $29,414
Urologic Diseases 2017 NCI 5R01CA205400-02 Distinct Redox Mechanism in Normal and Cancer Cells as a Novel Therapeutic Target ST CLAIR, DARET UNIVERSITY OF KENTUCKY KY $339,072
Urologic Diseases 2017 NINDS 5R01NS070267-08 Bladder, Urethra and Anal Sphincter Reinnervation RUGGIERI, MICHAEL TEMPLE UNIV OF THE COMMONWEALTH PA $591,621
Urologic Diseases 2017 NIAID 5R01AI029549-27 CHAPERONE ASSISTED PILI ASSEMBLY IN PATHOGENIC E COLI HULTGREN, SCOTT WASHINGTON UNIVERSITY MO $381,251
Urologic Diseases 2017 NCI 5R01CA188015-03 Discovery of Selective MAP2K4 Inhibitors to Target Metastasis SCHEIDT, KARL NORTHWESTERN UNIVERSITY IL $346,802
Urologic Diseases 2017 NIAID 5R01AI117064-03 Consortium for drug-resistant Gram-negative pathogen detection RILEY, LEE UNIVERSITY OF CALIFORNIA BERKELEY CA $1,185,876
Urologic Diseases 2017 NIAID 5R01AI106934-04 Nuclear Sensing of Herpesviral DNA KNIPE, DAVID HARVARD MEDICAL SCHOOL MA $443,487
Urologic Diseases 2017 NCI 5R01CA188427-03 Regulation of tyrosine kinase signaling through interaction with membrane lipids TYNER, ANGELA UNIVERSITY OF ILLINOIS AT CHICAGO IL $430,308
Urologic Diseases 2017 NCI 5K99CA197804-02 Epigenetic Mechanisms Controlling T-cell Exhaustion in Prostate Cancer KISSICK, HAYDN EMORY UNIVERSITY GA $111,730
Urologic Diseases 2017 NCI 5R01CA172384-05 The Role of NOV (CCN3) in Prostate Cancer Progression YU, JINDAN NORTHWESTERN UNIVERSITY AT CHICAGO IL $320,588
Urologic Diseases 2017 NIDDK 5R01DK092202-07 Prostate Epithelial Lineage Hierarchy XIN, LI BAYLOR COLLEGE OF MEDICINE TX $356,625
Urologic Diseases 2017 NCI 5P30CA051008-24 6490 Cancer Prevention and Control WEINER, LOUIS GEORGETOWN UNIVERSITY DC $39,440
Urologic Diseases 2017 NIMHD 5R01MD008934-04 Decision Aids to Address Prostate Cancer Disparities in Minority Men TILBURT, JON MAYO CLINIC ROCHESTER MN $358,055
Urologic Diseases 2017 NIAID 5U19AI110818-04 6826 Genomics of bacterial pathogens: host response, persistence and transmission EARL, ASHLEE BROAD INSTITUTE, INC. MA $1,030,859
Urologic Diseases 2017 NCI 5R01CA198097-02 Co-targeting oncogenic pathways in advanced prostate cancer CICHOWSKI, KAREN BRIGHAM AND WOMEN'S HOSPITAL MA $381,212
Urologic Diseases 2017 NIDDK 5K08DK106472-03 Mechanisms of Cellular Adaptation in Cystitis CLAYTON, DOUGLASS VANDERBILT UNIVERSITY MEDICAL CENTER TN $147,852
Urologic Diseases 2017 NIAID 1R43AI129008-01 Aminospectinomycin antibacterials for the treatment of antibiotic-resistant gonorrhea and other bacterial STDs BUTLER, MICHELLE MICROBIOTIX, INC MA $296,845
Urologic Diseases 2017 NIDDK 2SB1DK107094-04 Commercial readiness of kidney stone repositioning – The SonoMotion solution LEVY, OREN SONOMOTION, INC. CA $470,748
Urologic Diseases 2017 NCI 5R01CA200859-02 Hardwiring Mechanism into Predicting Cancer Phenotypes by Computational Learning MARCHIONNI, LUIGI JOHNS HOPKINS UNIVERSITY MD $384,981
Urologic Diseases 2017 NICHD 5R01HD056275-10 Cesarean and vaginal birth: cohort study of the impact on pelvic floor disorders HANDA, VICTORIA JOHNS HOPKINS UNIVERSITY MD $583,493
Urologic Diseases 2017 NIAID 5R01AI117032-03 A Droplet-based single cell platform for pathogen identification and AST WANG, TZA-HUEI JOHNS HOPKINS UNIVERSITY MD $1,168,562
Urologic Diseases 2017 NCI 1R44CA210820-01A1 ZW800-1: The 1st Zwitterionic NIR Fluorophore for Cancer Imaging & Ureter Mapping FRANGIONI, JOHN CURADEL, LLC MA $989,401
Urologic Diseases 2017 NIAID 1R41AI129106-01 A novel anti-gonorrhea immunotherapeutic WYCOFF, KEITH PLANET BIOTECHNOLOGY, INC. CA $242,093
Urologic Diseases 2017 NIAID 1R44AI129031-01 Low-Cost Instrument-free Point-of-Care Diagnostic for Neisseria gonorrhoeae MITRA, DEBKISHORE DIASSESS CA $716,689
Urologic Diseases 2017 NCI 5U01CA179106-04 Biomarkers for Staging and Treatment Response Monitoring of Bladder Cancer HADJIYSKI, LUBOMIR UNIVERSITY OF MICHIGAN MI $548,074
Urologic Diseases 2017 NCI 5R01CA189765-03 CXCL13: a mediator of prostate cancer progression KAZANIETZ, MARCELO UNIVERSITY OF PENNSYLVANIA PA $356,098
Urologic Diseases 2017 NIDDK 5F32DK102277-03 Mechanisms facilitating the persistent colonization of oxalate-degrading bacteria MILLER, AARON CLEVELAND CLINIC LERNER COM-CWRU OH $60,990
Urologic Diseases 2017 NCI 1F32CA213742-01 Establishing in vitro carcinoma models of the Alternative Lengthening of Telomeres pathway to elucidate molecular mechanisms and identify therapeutic vulnerabilities GRAHAM, MINDY JOHNS HOPKINS UNIVERSITY MD $57,066
Urologic Diseases 2017 NCI 5R01CA154387-05 Inhibiting serine protease-induced prostate cancer progression RADISKY, EVETTE MAYO CLINIC JACKSONVILLE FL $325,287
Urologic Diseases 2017 NIA 5R21AG047594-02 Overactive Bladder Urothelium: The ACh loop, immune response and microbiota LE, PHONG LOYOLA UNIVERSITY CHICAGO IL $223,388
Urologic Diseases 2017 NIAID 5R01AI119675-02 Conformational dynamics of adhesive bonds THOMAS, WENDY UNIVERSITY OF WASHINGTON WA $596,525
Urologic Diseases 2017 NIGMS 5SC1CA180212-05 Role of CCL25-CCR9 in Prostate Cancer SINGH, SHAILESH MOREHOUSE SCHOOL OF MEDICINE GA $353,750
Urologic Diseases 2017 NIDDK 5R01DK096238-05 Early Validation of Urinary Biomarkers of Renal Obstruction LEE, RICHARD BOSTON CHILDREN'S HOSPITAL MA $265,500
Urologic Diseases 2017 NCI 1F31CA203036-01A1 Bone Marrow Adipocytes Alter the Metabolic Phenotype of Metastatic Prostate Cancer Cells Through the Activation of HIF-1a DIEDRICH, JONATHAN WAYNE STATE UNIVERSITY MI $28,447
Urologic Diseases 2017 NCI 1F30CA206333-01A1 Investigating the Role of the Tumor MicroEnvironment in Resistance of Urothelial Carcinoma of the Bladder to FGFR3 Inhibition CLAUNCH-RABE, CHERYL OREGON HEALTH & SCIENCE UNIVERSITY OR $49,044
Urologic Diseases 2017 NCI 5U01CA113913-12 Emory, Harvard & Univ. of Washington Prostate Cancer Biomarker Center SANDA, MARTIN EMORY UNIVERSITY GA $874,523
Urologic Diseases 2017 NCI 5R01CA123362-06 PDGF D and Prostate Cancer Bone Metastasis KIM, HYEONG-REH WAYNE STATE UNIVERSITY MI $354,346
123456


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer